Oppenheimer Asset Management Inc. Apellis Pharmaceuticals, Inc. Put Options Transaction History
Oppenheimer Asset Management Inc.
- $6.65 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
336Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$564 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$425 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$416 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$356 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$206 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.11B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...